A comparative study of 500 mg BID and 250 mg BID of prophylactic oral ganciclovir in post-kidney transplant 'CMV at risk' recipients

  • H. C. Yang
  • , M. J. Holman
  • , E. Langhoff
  • , C. A. Dellock
  • , M. Gupta
  • , P. J. Ulsh
  • , N. Ahsan

Research output: Contribution to journalArticlepeer-review

8 Scopus citations
Original languageEnglish
Pages (from-to)1125-1126
Number of pages2
JournalTransplantation Proceedings
Volume31
Issue number1-2
DOIs
StatePublished - Feb 1999
Externally publishedYes

Cite this